The fund aims to provide long term growth and is designed for investors who are looking for exposure to European equity markets, excluding the UK. The fund invests predominantly in the shares of companies listed on European stock markets and is actively managed by our investment team, who will select stocks to try to take advantage of opportunities they have identified.
Name | % Net Assets |
---|---|
Sanofi | 3.1% |
SAP | 2.8% |
Novo Nordisk B | 2.5% |
Anheuser-Busch InBev NV | 2.4% |
UCB | 2.3% |
Continental | 2.2% |
Trygvesta A/S | 2.2% |
Volvo AB | 2.2% |
Dragon Oil | 2.1% |
Banco Santander Central Hispano | 2.1% |
Key | % Net Assets |
---|---|
Sanofi | 3.1% |
SAP | 2.8% |
Novo Nordisk B | 2.5% |
Anheuser-Busch InBev NV | 2.4% |
Other | 89.2% |
Date | 03-Mar-2023 |
---|---|
NAV | 312.90p |
Currency | GBP |
Change | 4.60p |
% | 1.49% |
YTD change | 312.90p |
YTD % | n/a |
Fund Inception | 16/11/1998 |
---|---|
Fund Manager | Jaime Ramos-Martin |
TER | 0.93 (28-Sep-2012) |
Minimum Investment | |
---|---|
Initial | £250000 |
Additional | £50,000 |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.03 |
Sharpe ratio | 0.12 |
You are here: research